← Back to Search

Protein Shakes for Aging Recovery (GRIPS Trial)

Phase 1
Recruiting
Led By Elena Volpi, MD, PhD
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 65 years or older.
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 30 days after discharge
Awards & highlights

GRIPS Trial Summary

This trial will determine if protein shakes can help older adults recover from hospital stays and maintain physical function.

Who is the study for?
This trial is for English-speaking adults aged 65 or older who have been admitted to UTMB hospital for any acute medical condition. It's not suitable for those unable to consent, bed/wheelchair-bound before hospitalization, with severe kidney disease, high liver enzymes, active cancer, in palliative care/hospice, or already on a high-protein diet.Check my eligibility
What is being tested?
The study aims to see if nutritional supplements like whey protein and collagen can help seniors recover their physical function after a hospital stay. Participants will be randomly given either one of these proteins or a placebo to assess the effects on their recovery.See study design
What are the potential side effects?
Potential side effects from the protein supplements may include digestive discomfort such as bloating or gas. Those with lactose intolerance might experience more pronounced symptoms when taking whey protein.

GRIPS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.

GRIPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 30 days after discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 30 days after discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Function

GRIPS Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Whey ProteinActive Control1 Intervention
30 g of whey protein twice daily during hospitalization and for 30 days after discharge
Group II: Collagen ProteinActive Control1 Intervention
30 g of collagen protein twice daily during hospitalization and for 30 days after discharge
Group III: PlaceboPlacebo Group1 Intervention
30 g of maltodextrin twice daily during hospitalization and for 30 days after discharge

Find a Location

Who is running the clinical trial?

The University of Texas Medical Branch, GalvestonLead Sponsor
243 Previous Clinical Trials
56,511 Total Patients Enrolled
10 Trials studying Aging
718 Patients Enrolled for Aging
Dairy Management Inc.Industry Sponsor
20 Previous Clinical Trials
2,466 Total Patients Enrolled
Elena Volpi, MD, PhDPrincipal InvestigatorUTMB
6 Previous Clinical Trials
2,652 Total Patients Enrolled
3 Trials studying Aging
288 Patients Enrolled for Aging

Media Library

Whey Protein Clinical Trial Eligibility Overview. Trial Name: NCT03904615 — Phase 1
Aging Research Study Groups: Whey Protein, Collagen Protein, Placebo
Aging Clinical Trial 2023: Whey Protein Highlights & Side Effects. Trial Name: NCT03904615 — Phase 1
Whey Protein 2023 Treatment Timeline for Medical Study. Trial Name: NCT03904615 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
Jennie Sealy Hospital
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I have dealt with a number health issues from bone infection and replacement of left, being for over a year. Colon Cancer surgery and Chemo in 2022. And currently dealing with stage IV prostate cancer.
PatientReceived 1 prior treatment
~27 spots leftby Apr 2025